Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: Fertil Steril. 2014 Jun 14;102(3):774–781.e3. doi: 10.1016/j.fertnstert.2014.05.026

Figure 1. Anti-Mullerian Hormone levels and Antral Follicle Counts for visits in HC users vs. visits in non-users stratified by cancer history.

Figure 1

Figure 1

Data for A.) Anti-Mullerian Hormone and B.) Antral Follicle Count are presented as unadjusted geometric means and 95% confidence intervals. Graphs include data from 61 visits among survivors recently exposed to hormonal contraception, 191 visits among survivors not recently exposed to hormonal contraception, 11 visits among healthy controls recently exposed to hormonal contraception, and 229 visits among healthy controls not recently exposed to hormonal contraception.